FDCDDQ
WST icon

Federation des caisses Desjardins du Quebec’s West Pharmaceutical WST Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
4,804
+1,763
+58% +$539K 0.01% 879
2026
Q1 		$762K Buy
3,041
+607
+25% +$151K ﹤0.01% 1104
2025
Q4 		$670K Buy
2,434
+32
+1% +$8.75K ﹤0.01% 1167
2025
Q3 		$630K Sell
2,402
-244
-9% -$59.3K ﹤0.01% 1133
2025
Q2 		$579K Sell
2,646
-123
-4% -$26.3K ﹤0.01% 1006
2025
Q1 		$620K Buy
2,769
+364
+15% +$100K ﹤0.01% 961
2024
Q4 		$788K Buy
2,405
+706
+42% +$222K ﹤0.01% 850
2024
Q3 		$510K Buy
1,699
+29
+2% +$8.88K ﹤0.01% 951
2024
Q2 		$550K Buy
1,670
+771
+86% +$272K ﹤0.01% 913
2024
Q1 		$345K Buy
899
+578
+180% +$214K ﹤0.01% 954
2023
Q4 		$113K Buy
321
+169
+111% +$59.8K ﹤0.01% 1086
2023
Q3 		$57K Sell
152
-35
-19% -$13.5K ﹤0.01% 1274
2023
Q2 		$71.5K Sell
187
-38
-17% -$13.6K ﹤0.01% 1237
2023
Q1 		$78K Sell
225
-405
-64% -$118K ﹤0.01% 1201
2022
Q4 		$148K Sell
630
-31
-5% -$7.35K ﹤0.01% 1140
2022
Q3 		$163K Sell
661
-86
-12% -$26.2K ﹤0.01% 1153
2022
Q2 		$226K Sell
747
-1,787
-71% -$581K ﹤0.01% 1079
2022
Q1 		$1.04M Buy
2,534
+1,085
+75% +$425K 0.01% 638
2021
Q4 		$679K Buy
1,449
+540
+59% +$232K 0.01% 764
2021
Q3 		$386K Sell
909
-76
-8% -$32K ﹤0.01% 953
2021
Q2 		$353K Buy
985
+236
+32% +$78K ﹤0.01% 999
2021
Q1 		$211K Hold
749
– – ﹤0.01% 1106
2020
Q4 		$212K Buy
749
+691
+1,191% +$194K ﹤0.01% 1052
2020
Q3 		$15.9K Hold
58
– – ﹤0.01% 1557
2020
Q2 		$13.2K Buy
58
+17
+41% +$3.34K ﹤0.01% 1558
2020
Q1 		$6.24K Sell
41
-158
-79% -$24.3K ﹤0.01% 1771
2019
Q4 		$29.9K Sell
199
-25
-11% -$3.64K ﹤0.01% 1639
2019
Q3 		$31.8K Buy
224
+137
+157% +$18.9K ﹤0.01% 1577
2019
Q2 		$10.9K Buy
+87
New +$10.3K ﹤0.01% 1836

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's WST Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its West Pharmaceutical (WST) stake by 58% in Q2 2026, buying an estimated $539K and bringing the position to 4,804 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #879.

Federation des caisses Desjardins du Quebec first reported a position in WST in Q2 2019 and has held it in 29 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 4,804 shares of West Pharmaceutical worth $1.72M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 1,763 West Pharmaceutical shares in Q2 2026, an estimated $539K.
  • West Pharmaceutical made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #879 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in West Pharmaceutical in Q2 2019 and has held it in 29 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.